📰 Forward Looking News
Page 28 - Forward Looking News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Forward Looking. Real-time updates on events, politics, business and more.
January 3, 2023
Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023 Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022 GlobeNewswire January 03, 2023 SINGAPORE, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments...
January 3, 2023
/PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased...
January 3, 2023
/PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased...
December 28, 2022
Investegate announcements from Fresnillo Plc, Juanicipio project update
December 28, 2022
Investegate announcements from Marble Point Ln Fin, Dividend Declaration
December 23, 2022
Sonar System Market Scenario Highlighting Major Drivers & Growth Forecast by 2027
December 23, 2022
Sonar System Market Scenario Highlighting Major Drivers & Growth Forecast by 2027
December 16, 2022
(Archived document, may contain errors) 7/3/85 84 LAST-CHANCE FOR THE NAI ROB I WOMEN'S CONFERENCE
December 14, 2022
/PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis...
December 13, 2022
Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin Lymphoma GlobeNewswire December 12, 2022 Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete...